As a member of the myotubularin family of phosphoinositide lipid phosphatases, MTMR2 promotes gastric cancer development via the IFNγ/STAT1/IRF1 pathway and facilitates NK/T‐cell lymphoma progression by targeting JAK1.59, 60. Here, STAT1 is linked to gastric cancer.